Active substance
Carisoprodol
- US FDA 27
- US price lines 3
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| SOMA | 350MG; 250MG | tablet · oral | MYLAN SPECIALITY LP | Prescription | 9 Apr 1959 |
| CARISOPRODOL | 350MG | tablet · oral | WATSON LABS | Prescription | 20 Apr 1982 |
| CARISOPRODOL | 350MG | tablet · oral | PHARMAZONE | Prescription | 13 Apr 1989 |
| CARISOPRODOL | 350MG | tablet · oral | OXFORD PHARMS | Prescription | 7 Mar 1997 |
| CARISOPRODOL | 350MG | tablet · oral | CHARTWELL RX | Prescription | 8 Sep 1997 |
| CARISOPRODOL | 350MG | tablet · oral | ACCELRX LABS | Prescription | 7 Jun 2005 |
| CARISOPRODOL | 350MG | tablet · oral | INGENUS PHARMS LLC | Prescription | 22 Oct 2008 |
| CARISOPRODOL | 350MG; 250MG | tablet · oral | AUROBINDO PHARMA | Prescription | 6 Aug 2009 |
| CARISOPRODOL | 350MG | tablet · oral | SCIEGEN PHARMS | Prescription | 27 Jan 2014 |
| CARISOPRODOL | 350MG | tablet · oral | ORIENT PHARMA CO LTD | Prescription | 27 Oct 2014 |
| CARISOPRODOL | 350MG | tablet · oral | NATCO | Prescription | 28 Oct 2014 |
| CARISOPRODOL | 250MG; 350MG | tablet · oral | HERITAGE | Prescription | 8 Jul 2015 |
| CARISOPRODOL | 250MG; 350MG | tablet · oral | MPP PHARMA | Prescription | 11 May 2017 |
| CARISOPRODOL | 350MG | tablet · oral | POINTVIEW HLDINGS | Prescription | 20 Oct 2021 |
| SOMA | 250MG | capsule · oral | MYLAN SPECIALITY LP | Discontinued | 9 Apr 1959 |
| CARISOPRODOL | 350MG | tablet · oral | WATSON LABS TEVA | Discontinued | 12 Jun 1979 |
| CARISOPRODOL | 350MG | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 17 Oct 1991 |
| CARISOPRODOL | 350MG | tablet · oral | HIKMA INTL PHARMS | Discontinued | 24 Jan 1996 |
| CARISOPRODOL | 350MG | tablet · oral | WATSON LABS | Discontinued | 3 Dec 1996 |
| CARISOPRODOL | 350MG | tablet · oral | EPIC PHARMA LLC | Discontinued | 21 Sep 2000 |
| CARISOPRODOL | 350MG | tablet · oral | ABLE | Discontinued | 21 Jun 2001 |
| CARISOPRODOL | 350MG | tablet · oral | SUN PHARM INDS LTD | Discontinued | 27 Feb 2007 |
| CARISOPRODOL | 250MG; 350MG | tablet · oral | STRIDES PHARMA | Discontinued | 12 Nov 2015 |
| CARISOPRODOL | 350MG | tablet · oral | WATSON LABS | Discontinued | |
| CARISOPRODOL | 350MG | tablet · oral | PIONEER PHARMS | Discontinued |
2 more — full table
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CARISOPRODOL 250 MG TABLET | $0.47389 | per EA | 23 Sep 2026 |
| US NADAC | CARISOPRODOL 350 MG TABLET | $0.07059 | per EA | 23 Sep 2026 |
| US NADAC | SOMA 350 MG TABLET | $11.29746 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 22 Aug 2018 SOMA — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.